Effects of seeding on lysozyme amyloid fibrillation in the presence of epigallocatechin and polyethylene glycol
Authors:
- 18 February 2017
- journal article
- Published by Pleiades Publishing Ltd in Biochemistry (Moscow)
- Vol. 82 (2) , 156-167
Abstract
Preformed amyloid fibrils can act as seeds for accelerating protein fibrillation. In the present study, we examined the effects of preformed seeds on lysozyme amyloid fibrillation in the presence of two distinct inhibitors–epigallocatechin (EGC) and polyethylene glycol 2000 (PEG). The results demonstrated that the effects of fibrillar seeds on the acceleration of lysozyme fibrillation depended on the aggregation pathway directed by an inhibitor. EGC inhibited lysozyme fibrillation and modified the peptide chains with quinone moieties in a concentration-dependent manner. The resulting aggregates showed amorphous off-pathway morphology. Preformed fibril seeds did not promote lysozyme fibrillation in the presence of EGC. PEG also inhibited lysozyme fibrillation, and the resulting aggregates showed on-pathway protofibrillar morphology. In contrast, the addition of fibril seeds into the mixture of lysozyme and PEG significantly stimulated fibril growth. Assays of cell viability showed that both EGC and PEG inhibited the formation of cytotoxic species. In accordance with thioflavine T data, the seeds failed to alter the cell-damaging potency of the EGC-directed off-pathway aggregates, but increased the cytotoxicity of the PEG-directed on-pathway fibrils. We suggest that the pattern of interaction between lysozyme and an inhibitor determines the pathway of aggregation and therefore the effects of seeding on amyloid formation. EGC covalently modified lysozyme chains with quinones, directing the aggregation to proceed through an off-pathway, whereas PEG affected the protein in a noncovalent manner, and fibril growth could be stimulated under seeding through an on-pathway.Keywords
This publication has 49 references indexed in Scilit:
- What Can the Kinetics of Amyloid Fibril Formation Tell about Off-pathway Aggregation?Journal of Biological Chemistry, 2016
- Amyloids: from pathogenesis to functionBiochemistry (Moscow), 2015
- A multi‐pathway perspective on protein aggregation: Implications for control of the rate and extent of amyloid formationFEBS Letters, 2015
- Intracellular seeded aggregation of mutant Cu,Zn‐superoxide dismutase associated with amyotrophic lateral sclerosisFEBS Letters, 2013
- Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptideProceedings of the National Academy of Sciences, 2009
- Cellular Membrane Disruption by Amyloid Fibrils Involved Intermolecular Disulfide Cross-LinkingBiochemistry, 2009
- EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomersNature Structural & Molecular Biology, 2008
- Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein worldBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2004
- Protein folding and misfoldingNature, 2003
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002